Tam-Bran Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 9.95 Cr
as on 04-07-2024
- Paid Up Capital ₹ 9.26 Cr
as on 04-07-2024
- Company Age 30 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.05 Cr
as on 04-07-2024
- Satisfied Charges ₹ 11.34 Cr
as on 04-07-2024
- Revenue 182.37%
(FY 2023)
- Profit 152.24%
(FY 2023)
- Ebitda 200.73%
(FY 2023)
- Net Worth 47.34%
(FY 2023)
- Total Assets 3.06%
(FY 2023)
About Tam-Bran Pharmaceuticals
The Corporate was formerly known as Tam-Bran Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.95 Cr and a paid-up capital of Rs 9.26 Cr.
The company currently has active open charges totaling ₹22.05 Cr. The company has closed loans amounting to ₹11.34 Cr, as per Ministry of Corporate Affairs (MCA) records.
Deependra Tamotia and Aditya Tamotia serve as directors at the Company.
- CIN/LLPIN
U02423MP1994PTC008677
- Company No.
008677
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Sep 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tam-Bran Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deependra Tamotia  | Managing Director | 30-Sep-1994 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aditya Tamotia | Director | 17-Sep-2011 | Current |
Financial Performance of Tam-Bran Pharmaceuticals.
Tam-Bran Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 182.37% increase. The company also saw a substantial improvement in profitability, with a 152.24% increase in profit. The company's net worth Soared by an impressive increase of 47.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tam-Bran Pharmaceuticals?
In 2023, Tam-Bran Pharmaceuticals had a promoter holding of 12.95% and a public holding of 87.05%. The company had 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
The-Adityaz News & Network Private LimitedActive 16 years 9 monthsDeependra Tamotia and Aditya Tamotia are mutual person
- Nayantara Constructions Private LimitedActive 28 years 4 months
Deependra Tamotia and Aditya Tamotia are mutual person
- The-Adityaz Hotels LimitedActive 23 years 9 months
Deependra Tamotia and Aditya Tamotia are mutual person
- Adityaz Multispeciality Hospital Private LimitedActive 9 months 27 days
Deependra Tamotia and Aditya Tamotia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Jul 2023 | ₹2.10 Cr | Open |
Others Creation Date: 19 Jul 2023 | ₹17.00 Cr | Open |
Others Creation Date: 26 Apr 2019 | ₹2.95 Cr | Open |
How Many Employees Work at Tam-Bran Pharmaceuticals?
Tam-Bran Pharmaceuticals has a workforce of 19 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tam-Bran Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tam-Bran Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
